Skip to main content

Table 2 Lesion and procedural characteristics

From: Clinical outcomes in 2481 unselected real-world patients treated with a polymer-free sirolimus-eluting stent: 3 years results from the NANO multicenter Registry

Variable

N = 2904

Target vessel

LMCA

96 (3.3%)

LAD

1278 (44.0%)

LCX

586 (20.2%)

TIMI flow grade preprocedure

0

599 (20.7%)

1

206 (7.1%)

2

218 (7.5%)

3

1871 (64.7%)

Thrombus present

474 (19.1%)

Thrombus aspiration

114 (5.7%)

Lesion complexity

AHA/ACC classification

A

428 (15.0%)

B1

428 (15.0%)

B2

506 (17.8%)

C

1315 (46.1%)

In-stent restenosis, n (%)

57 (2.0%)

Calcified lesion

169 (5.8%)

Bifurcated lesions

340 (11.7%)

Chronic total occlusion

422 (14.5%)

Severe tortuosity

79 (2.7%)

Lesion length ≥ 40 mm

460 (17.0%)

RVD < 2.5 mm

115 (4.1%)

Total stent diameter

3.11 ± 1.34

Total stent length, mm

25.99 ± 8.59

Post dilatation

2050 (70.6%)

Average maximal pressure (atm)

17.45 ± 3.82

Multiple vessel PCI

287 (11.6%)

Number of stents per lesion

1.33 ± 0.60

Number of stents per patient

1.56 ± 0.79

Device success

2385 (96.1%)

Procedural success

2368 (95.4%)

P2Y12 at discharge

Clopidogrel

1785 (71.9%)

Ticagrelor

696 (28.1%)

  1. Values are expressed as mean ± SD or n (%)
  2. ACC American College of Cardiology, AHA American Heart Association, LAD left anterior descending artery, LCX left circumflex artery, LMCA left main coronary artery, PCI percutaneous coronary intervention, RCA right coronary artery, TIMI thrombolysis in myocardial infarction, RVD referenced vessel diameter